Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Reger

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Parallel suspension polymerization for high-throughput resin synthesisThomas S Reger, Kim D Janda
Archives of Biochemistry and Biophysics|March 30, 2004
Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoformsKayo Sakaguchi, Mitchell Green, Nicholas Stock, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemiaNicholas D Smith, Thomas S Reger, Joseph Payne, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
2-(2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonistDehua Huang, Steve F Poon, Deborah F Chapman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2010
In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in miceRichard L Kraus, Yuxing Li, Yun Gregan, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2009
Heterocycle-substituted proline dipeptides as potent VLA-4 antagonistsThomas S Reger, Jasmine Zunic, Nicholas Stock, et al.
The Journal of Clinical Investigation|May 20, 2009
Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in miceVictor N Uebele, Anthony L Gotter, Cindy E Nuss, et al.
Veterinary Immunology and Immunopathology|March 3, 2009
Characterization of alpha(4)beta(1) (CD49d/CD29) on equine leukocytes: potential utility of a potent alpha(4)beta(1) (CD49d/CD29) receptor antagonist in the treatment of equine heaves (recurrent airway obstruction)Kelly M Treonze, Kenneth Alves, Paul Fischer, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonistsKelly-Ann S Schlegel, Zhi-Qiang Yang, Thomas S Reger, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Pyridyl amides as potent inhibitors of T-type calcium channelsThomas S Reger, Zhi-Qiang Yang, Kelly-Ann S Schlegel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Parallel suspension polymerization for high-throughput resin synthesisThomas S Reger, Kim D Janda
Archives of Biochemistry and Biophysics|March 30, 2004
Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoformsKayo Sakaguchi, Mitchell Green, Nicholas Stock, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemiaNicholas D Smith, Thomas S Reger, Joseph Payne, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
2-(2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonistDehua Huang, Steve F Poon, Deborah F Chapman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2010
In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in miceRichard L Kraus, Yuxing Li, Yun Gregan, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2009
Heterocycle-substituted proline dipeptides as potent VLA-4 antagonistsThomas S Reger, Jasmine Zunic, Nicholas Stock, et al.
The Journal of Clinical Investigation|May 20, 2009
Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in miceVictor N Uebele, Anthony L Gotter, Cindy E Nuss, et al.
Veterinary Immunology and Immunopathology|March 3, 2009
Characterization of alpha(4)beta(1) (CD49d/CD29) on equine leukocytes: potential utility of a potent alpha(4)beta(1) (CD49d/CD29) receptor antagonist in the treatment of equine heaves (recurrent airway obstruction)Kelly M Treonze, Kenneth Alves, Paul Fischer, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonistsKelly-Ann S Schlegel, Zhi-Qiang Yang, Thomas S Reger, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Pyridyl amides as potent inhibitors of T-type calcium channelsThomas S Reger, Zhi-Qiang Yang, Kelly-Ann S Schlegel, et al.
Pageof 2